Department of Pharmacy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
Department of Clinical Laboratory, Guizhou Provincial Orthopedic Hospital, Guiyang City, China.
Front Immunol. 2022 Jun 15;13:915047. doi: 10.3389/fimmu.2022.915047. eCollection 2022.
The gut microbiota is composed of a large number of microorganisms with a complex structure. It participates in the decomposition, digestion, and absorption of nutrients; promotes the development of the immune system; inhibits the colonization of pathogens; and thus modulates human health. In particular, the relationship between gut microbiota and gastrointestinal tumor progression has attracted widespread concern. It was found that the gut microbiota can influence gastrointestinal tumor progression in independent ways. Here, we focused on the distribution of gut microbiota in gastrointestinal tumors and further elaborated on the impact of gut microbiota metabolites, especially short-chain fatty acids, on colorectal cancer progression. Additionally, the effects of gut microbiota on gastrointestinal tumor therapy are outlined. Finally, we put forward the possible problems in gut microbiota and the gastrointestinal oncology field and the efforts we need to make.
肠道微生物群由大量具有复杂结构的微生物组成。它参与营养物质的分解、消化和吸收;促进免疫系统的发育;抑制病原体的定植;从而调节人体健康。特别是肠道微生物群与胃肠道肿瘤进展的关系引起了广泛关注。研究发现,肠道微生物群可以通过独立的方式影响胃肠道肿瘤的进展。在这里,我们重点关注了肠道微生物群在胃肠道肿瘤中的分布,并进一步阐述了肠道微生物群代谢物,特别是短链脂肪酸对结直肠癌进展的影响。此外,还概述了肠道微生物群对胃肠道肿瘤治疗的影响。最后,我们提出了肠道微生物群和胃肠肿瘤学领域可能存在的问题以及我们需要努力的方向。